Key facts
| Price (PPV) | 41.30 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbésartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA04 |
| Manufacturer | SYNTHEMEDIC |
| Presentation | Boite de 30 |
| Nature | Médicament |
| Hospital price | 25.80 MAD |
| Data collected on | 9/8/2026 |
Indications
L’irbersartan est indiqué chez l’adulte dans le traitement de l’ hypertension artérielle essentielle. Il est également indiqué dans le traitement de l’atteinte rénale chez les patients adultes hypertendus diabétiques de type 2, dans le cadre de la prise en charge par un médicament antihypertenseur.
Find an open pharmacy
On-call pharmacies near you
About Vezar 75 mg
Vezar 75 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SYNTHEMEDIC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Vezar 75 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Vezar 75 mg
Answers to common questions from Moroccan patients about this drug.